Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions in VKORC1.

@article{Harrington2008PharmacodynamicRT,
  title={Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions in VKORC1.},
  author={D J Harrington and Renata A. G{\'o}rska and Richard Wheeler and Sally H. Davidson and Sherina L Murden and Colin V Morse and Martin J. Shearer and Andrew Mumford},
  journal={Journal of thrombosis and haemostasis : JTH},
  year={2008},
  volume={6 10},
  pages={
          1663-70
        }
}

• D J Harrington, Renata A. Górska, +5 authors Andrew Mumford
• Published 2008 in Journal of thrombosis and haemostasis : JTH
• DOI:10.1111/j.1538-7836.2008.03116.x

BACKGROUND Vitamin K epoxide reductase subunit 1 (VKORC1) is the molecular target of coumarin anticoagulants and mutations in VKORC1 have been identified previously in individuals who required high warfarin doses. OBJECTIVE Detailed characterization of the relationship between variation in VKORC1 and the warfarin resistance phenotype. PATIENTS AND METHODS Serum warfarin concentration and coagulation parameters were determined in 289 subjects who required warfarin doses >20 mg day(-1). The… CONTINUE READING

Save to Library

Create Alert

Cite

View on PubMed